Is ARHGAP4 p.Ala611Val (c.1832C>T) pathogenic?

ARHGAP4 p.Ala611Val (c.1832C>T) is classified Uncertain significance in ARHGAP4 (ClinVar, Single submitter, 1 submitter; last evaluated 2025-11-20). AlphaMissense: likely benign (0.0763); Ultra-rare (popmax 0.0477%, mid).

How common is ARHGAP4 p.Ala611Val (c.1832C>T) in the general population?

ARHGAP4 p.Ala611Val (c.1832C>T) is ultra-rare (popmax 0.0477%, mid) (gnomAD).

What do computational predictors say about ARHGAP4 p.Ala611Val (c.1832C>T)?

AlphaMissense predicts likely benign (score 0.0763) — an in-silico prediction, not a clinical call.

ARHGAP4 p.Ala611Val

c.1832C>T · VCV4642451

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0763 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0477%, mid)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0763	likely benign
REVEL	0.026	moderately benign-leaning
SaProt	LLR -8.02	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.95	GERP -2.8
Regional constraint	o/e 1.15	unconstrained · MANE · 3,070 bp · p 0.006 · regional, not allelic
Overall
CADD	9.403	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0477% Middle Eastern · 2/4,196 alleles

Filtering AF 0.0084% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00601%

Overall 0.00282% 34/1,205,498 alleles · ultra-rare

Ancestry group	Frequency	1 in
Middle Easterngrpmax	0.0477%	2,098
African / African-American	0.0157%	6,383
South Asian	0.00887%	11,279
Remaining individualsnot grpmax-eligible	0.00633%	15,799
East Asian	0.00297%	33,650
European (non-Finnish)	0.00157%	63,829

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: ARHGAP4
Protein: p.Ala611Val
Coding: c.1832C>T
MANE Select: NM_001666
Type: single nucleotide variant
Location: chrX:153910596 (GRCh38)
Structure: AlphaFold pLDDT 76.48 · 1 PDB
Residue 611: the rho-gap domain

Full ARHGAP4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

ARHGAP4 p.Val705Ile Uncertain significance ★★ ⚠ same type
ARHGAP4 c.2415-4G>A Benign ★★ same type
ARHGAP4 c.2608-6C>T Benign ★★ same type
ARHGAP4 p.Asp420= Benign ★★ same type
ARHGAP4 p.His572= Benign ★★ same type
ARHGAP4 p.Pro627= Benign ★★ same type
ARHGAP4 c.682-292A>C Uncertain significance ★ same type
ARHGAP4 c.682-302C>G Uncertain significance ★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/arhgap4-p-ala611val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown